414 related articles for article (PubMed ID: 29498457)
1. Rikkunshito simultaneously improves dyspepsia correlated with anxiety in patients with functional dyspepsia: A randomized clinical trial (the DREAM study).
Tominaga K; Sakata Y; Kusunoki H; Odaka T; Sakurai K; Kawamura O; Nagahara A; Takeuchi T; Fujikawa Y; Oshima T; Kato M; Furuta T; Murakami K; Chiba T; Miwa H; Kinoshita Y; Higuchi K; Kusano M; Iwakiri R; Fujimoto K; Tack JF; Arakawa T
Neurogastroenterol Motil; 2018 Jul; 30(7):e13319. PubMed ID: 29498457
[TBL] [Abstract][Full Text] [Related]
2. The effect of rikkunshito on gastrointestinal symptoms and gastric motor function: The first study in a Belgian functional dyspepsia population.
Masuy I; Carbone F; Holvoet L; Vandenberghe A; Vanuytsel T; Tack J
Neurogastroenterol Motil; 2020 Feb; 32(2):e13739. PubMed ID: 31608532
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia--a multicenter, double-blind, randomized, placebo-controlled study.
Suzuki H; Matsuzaki J; Fukushima Y; Suzaki F; Kasugai K; Nishizawa T; Naito Y; Hayakawa T; Kamiya T; Andoh T; Yoshida H; Tokura Y; Nagata H; Kobayakawa M; Mori M; Kato K; Hosoda H; Takebayashi T; Miura S; Uemura N; Joh T; Hibi T; Tack J;
Neurogastroenterol Motil; 2014 Jul; 26(7):950-61. PubMed ID: 24766295
[TBL] [Abstract][Full Text] [Related]
4. Association of baseline plasma des-acyl ghrelin level with the response to rikkunshito in patients with functional dyspepsia.
Togawa K; Matsuzaki J; Kobayakawa M; Fukushima Y; Suzaki F; Kasugai K; Nishizawa T; Naito Y; Hayakawa T; Kamiya T; Andoh T; Yoshida H; Tokura Y; Nagata H; Mori M; Kato K; Hosoda H; Takebayashi T; Miura S; Uemura N; Joh T; Hibi T; Suzuki H
J Gastroenterol Hepatol; 2016 Feb; 31(2):334-41. PubMed ID: 26252950
[TBL] [Abstract][Full Text] [Related]
5. Relationship between symptom pattern, assessed by the PAGI-SYM questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia.
Kindt S; Dubois D; Van Oudenhove L; Caenepeel P; Arts J; Bisschops R; Tack J
Neurogastroenterol Motil; 2009 Nov; 21(11):1183-e105. PubMed ID: 19663903
[TBL] [Abstract][Full Text] [Related]
6. Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders.
Revicki DA; Rentz AM; Tack J; Stanghellini V; Talley NJ; Kahrilas P; De La Loge C; Trudeau E; Dubois D
Clin Gastroenterol Hepatol; 2004 Sep; 2(9):769-77. PubMed ID: 15354277
[TBL] [Abstract][Full Text] [Related]
7. Rikkunshito improves the symptoms in patients with functional dyspepsia, accompanied by an increase in the level of plasma ghrelin.
Arai M; Matsumura T; Tsuchiya N; Sadakane C; Inami R; Suzuki T; Yoshikawa M; Imazeki F; Yokosuka O
Hepatogastroenterology; 2012; 59(113):62-6. PubMed ID: 22260823
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Xiangsha Liujunzi granules for functional dyspepsia: A multi-center randomized double-blind placebo-controlled clinical study.
Lv L; Wang FY; Ma XX; Li ZH; Huang SP; Shi ZH; Ji HJ; Bian LQ; Zhang BH; Chen T; Yin XL; Tang XD
World J Gastroenterol; 2017 Aug; 23(30):5589-5601. PubMed ID: 28852318
[TBL] [Abstract][Full Text] [Related]
9. Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study.
Braak B; Klooker TK; Wouters MM; Lei A; van den Wijngaard RM; Boeckxstaens GE
Aliment Pharmacol Ther; 2011 Sep; 34(6):638-48. PubMed ID: 21767283
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of oral Zhizhu Kuanzhong, a traditional Chinese medicine, in patients with postprandial distress syndrome.
Xiao Y; Li Y; Shu J; Li Y; Xu J; Ren J; Liu D; Wang J; Zhou L; Li Y; Tang G; Tian D; Zhang S; Hou X; Wang H; Li Z; Lv N; Chen M
J Gastroenterol Hepatol; 2019 Mar; 34(3):526-531. PubMed ID: 30207000
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia.
Kusunoki H; Haruma K; Hata J; Ishii M; Kamada T; Yamashita N; Honda K; Inoue K; Imamura H; Manabe N; Shiotani A; Tsunoda T
Intern Med; 2010; 49(20):2195-202. PubMed ID: 20962437
[TBL] [Abstract][Full Text] [Related]
12. An Herbal Formulation of Jiawei Xiaoyao for the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Placebo-Controlled, Clinical Trial.
Chen G; Feng P; Wang S; Ding X; Xiong J; Wu J; Wang L; Chen W; Chen G; Han M; Zou T; Li L; Du H
Clin Transl Gastroenterol; 2020 Oct; 11(10):e00241. PubMed ID: 33108123
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Rikkunshito for Functional Heartburn: A Prospective Pilot Study.
Kawami N; Hoshino S; Hoshikawa Y; Tanabe T; Koeda M; Momma E; Takenouchi N; Hanada Y; Kaise M; Iwakiri K
J Nippon Med Sch; 2022 Mar; 89(1):56-65. PubMed ID: 33692303
[TBL] [Abstract][Full Text] [Related]
14. A clinical study on safety and efficacy of Naesohwajung-tang on functional dyspepsia.
Ha NY; Kim S; Ko SJ; Park JW; Kim J
Medicine (Baltimore); 2020 May; 99(21):e19910. PubMed ID: 32481255
[TBL] [Abstract][Full Text] [Related]
15. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders.
Rentz AM; Kahrilas P; Stanghellini V; Tack J; Talley NJ; de la Loge C; Trudeau E; Dubois D; Revicki DA
Qual Life Res; 2004 Dec; 13(10):1737-49. PubMed ID: 15651544
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and Safety of New Prokinetic Agent Benachio Q Solution® in Patients with Postprandial Distress Syndrome Subtype in Functional Dyspepsia: A Single-center, Randomized, Double-blind, Placebo-controlled Pilot Study].
Shim YK; Lee JY; Kim NY; Park YH; Yoon H; Shin CM; Park YS; Lee DH
Korean J Gastroenterol; 2015 Jul; 66(1):17-26. PubMed ID: 26194125
[TBL] [Abstract][Full Text] [Related]
17. A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Comparative Clinical Study to Evaluate the Efficacy and Safety of OLNP-06
Panda MPharm SK; Nirvanashetty PhD S; Parachur BTech VA; Krishnamoorthy MPharm C; Dey MSc S
J Diet Suppl; 2022; 19(2):226-237. PubMed ID: 33305631
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia.
Tack J; Van Den Elzen B; Tytgat G; Wajs E; Van Nueten L; De Ridder F; Boeckxstaens G
Neurogastroenterol Motil; 2009 Jun; 21(6):619-26, e23-4. PubMed ID: 19220756
[TBL] [Abstract][Full Text] [Related]
19. Real-World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Treatment of Functional Dyspepsia.
Porika SK; Veligandla KC; Muni SK; Acharya S; Mehta SC; Sharma AD
Adv Ther; 2018 Nov; 35(11):1884-1893. PubMed ID: 30350248
[TBL] [Abstract][Full Text] [Related]
20. Effects of acotiamide on functional dyspepsia patients with heartburn who failed proton pump inhibitor treatment in Japanese patients: A randomized, double-blind, placebo-controlled crossover study.
Funaki Y; Ogasawara N; Kawamura Y; Yoshimine T; Tamura Y; Izawa S; Ebi M; Sasaki M; Kasugai K
Neurogastroenterol Motil; 2020 Feb; 32(2):e13749. PubMed ID: 31612597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
